Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 18;30(1):639.
doi: 10.1186/s40001-025-02911-x.

Cryoballoon versus radiofrequency ablation for persistent atrial fibrillation: an updated systematic review and meta‑analysis

Affiliations
Review

Cryoballoon versus radiofrequency ablation for persistent atrial fibrillation: an updated systematic review and meta‑analysis

Yi-Meng Gao et al. Eur J Med Res. .

Abstract

Background: Compared with paroxysmal atrial fibrillation, persistent atrial fibrillation (AF) is more harmful and difficult to treat, and the efficacy of different catheter ablation for both also varies greatly. So this study aimed to systematically evaluate the efficacy and safety of cryoballoon (CB) and radiofrequency (RF) ablation in the treatment of persistent AF.

Methods: We searched the PubMed, Embase, and Cochrane library databases for studies comparing the efficacy and safety between CB and RF ablation for persistent AF. All included studies met our inclusion criteria.

Results: A total of 11 studies, 2551 patients were enrolled in this study, including 1256 patients in CB group and 1295 patients in RF group. Meta-analysis results showed that the freedom from atrial tachyarrhythmia (ATA) recurrence was similar between the CB and RF groups (OR 1.00, 95% CI 0.85 to 1.18, I2 16%). The results of repeated ablation events in the two groups were similar (OR 0.85, 95% CI 0.64 to 1.12, I245%), while the operative time in the CB group was shorter than that in the RF group (mean reduction 45.27 min, 95% CI 61.34 to 29.20 min, I2 95%). There was no significant difference in fluoroscopy time between the two groups (mean difference 2.12 min, 95% CI 7.83 to 12.07 min, I2 99%). The incidence of total complications was similar between the two groups (OR 1.08, 95% CI 0.74 to 1.58, I2 0%), but phrenic nerve palsy (PNP) was more likely to occur in the CB group (OR 4.84, 95% CI 1.84 to 12.71, I2 0%). The incidence of pericardial tamponade was not statistically different between the two groups (OR 0.72, 95% CI 00.32 to 1.58, I2 0%).

Conclusions: CB can be used as an alternative therapy to RF for persistent AF, both of which have considerable efficacy and safety. CB can significantly reduce the operation time with the probability of high PNP.

Keywords: Cryoballoon ablation; Meta-analysis; Persistent atrial fibrillation; Radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: There are no ethical issues involved in this meta-analysis. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA Flow Diagram
Fig. 2
Fig. 2
Freedom from recurrent ATA with RF vs. CB ablation
Fig. 3
Fig. 3
Repeat ablation with RF vs. CB ablation
Fig. 4
Fig. 4
A Total procedural time with RF vs. CB ablation; B: Fluoroscopy time with RF vs. CB ablation
Fig. 5
Fig. 5
A Total complications with RF vs. CB ablation; B: PNP with RF vs. CB ablation; C: Cardiac tamponade with RF vs. CB ablation
Fig. 6
Fig. 6
A Subgroup analysis for freedom from ATA by trial RF ablation strategy (PVI only or additional ablation permitted) B: Subgroup analysis for procedure time by trial RF ablation strategy (PVI only or additional ablation permitted) C: Subgroup analysis for fluoroscopy time by trial RF ablation strategy (PVI only or additional ablation permitted)

Similar articles

References

    1. Benali K, et al. Impact of catheter ablation of atrial fibrillation on disease progression. JACC Clin Electrophysiol. 2025;11(2):421–35. - PubMed
    1. Hindricks G, et al. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges. Kardiol Pol. 2018;76(12):1680–6. - PubMed
    1. Van Gelder IC, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314–414. - PubMed
    1. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535. - PMC - PubMed
    1. Tzeis S, et al. 2024 European heart rhythm association/heart rhythm society/Asia pacific heart rhythm society/Latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26(4):43. - PMC - PubMed

MeSH terms